Effective November 28, 2023, Aeglea BioTherapeutics, Inc. will change its Nasdaq Capital Market stock ticker symbol to SYRE from AGLE.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.38 USD | +5.44% | +5.84% | +63.75% |
Apr. 19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Apr. 19 | Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.48% | 1.35B | |
-1.97% | 103B | |
+1.90% | 95.28B | |
+2.88% | 22.15B | |
-15.93% | 21.02B | |
-8.47% | 18.15B | |
-41.01% | 16.73B | |
-14.78% | 16.05B | |
+4.24% | 13.68B | |
+33.66% | 12.17B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Aeglea BioTherapeutics, Inc. will Change its Ticker to SYRE from AGLE